These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37939733)

  • 21. The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States.
    Vargo JA; Patel A; Glaser SM; Balasubramani GK; Farah RJ; Marks SM; Beriwal S
    Cancer; 2017 Aug; 123(16):3176-3185. PubMed ID: 28380259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase.
    Yang J; Li P; Piao Y; Liu X; Wei L; Sang W; Zhang L; Wang L
    Front Immunol; 2022; 13():829366. PubMed ID: 35371002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma.
    Liu X; Huang E; Wang Y; He Y; Luo H; Zhong M; Qiu D; Li C; Yang H; He G; Zhou J; Jin F
    Radiat Oncol; 2017 Apr; 12(1):76. PubMed ID: 28449713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.
    Lee N; Xia P; Quivey JM; Sultanem K; Poon I; Akazawa C; Akazawa P; Weinberg V; Fu KK
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):12-22. PubMed ID: 12007936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promising clinical outcomes of sequential and "Sandwich" chemotherapy and extended involved-field intensity-modulated radiotherapy in patients with stage I
    Wang HY; Niu SQ; Yang YY; Li YY; Chen HB; Zhang YJ
    Cancer Med; 2018 Dec; 7(12):5863-5869. PubMed ID: 30484966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensity-modulated radiation therapy followed by GDP chemotherapy for newly diagnosed stage I/II extranodal natural killer/T cell lymphoma, nasal type.
    Huang Y; Yang J; Liu P; Zhou S; Gui L; He X; Qin Y; Zhang C; Yang S; Xing P; Sun Y; Shi Y
    Ann Hematol; 2017 Sep; 96(9):1477-1483. PubMed ID: 28695246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of Primary Tumor Invasion and Regional Lymph Node Spread Based on Magnetic Resonance Imaging in Early-Stage Nasal NK/T-cell Lymphoma: Implications for Clinical Target Volume Definition and Prognostic Significance.
    Wu RY; Liu K; Wang WH; Jin J; Song YW; Wang SL; Liu YP; Ren H; Fang H; Liu QF; Yang Y; Chen B; Qi SN; Lu NN; Tang Y; Tang Y; Li N; Ouyang H; Li YX
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):50-59. PubMed ID: 27816363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group.
    Wu T; Yang Y; Zhu SY; Shi M; Su H; Wang Y; He X; Xu LM; Yuan ZY; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Wu JX; Hu C; Qi SN; Chen B; Li YX
    Blood Adv; 2018 Sep; 2(18):2369-2377. PubMed ID: 30242098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcomes of upfront concurrent chemoradiotherapy followed by P-GDP regimen in newly diagnosed early stage extranodal nasal-type NK/T cell lymphoma: A prospective single-center phase II study.
    Zhu F; Liu T; Pan H; Xiao Y; Li Q; Liu X; Chen W; Wu G; Zhang L
    Medicine (Baltimore); 2020 Aug; 99(33):e21705. PubMed ID: 32872045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity Modulated Radiation Therapy for Early-Stage Primary Gastric Diffuse Large B-Cell Lymphoma: Dosimetric Analysis, Clinical Outcome, and Quality of Life.
    Liu X; Fang H; Tian Y; Wang WH; Song YW; Wang SL; Liu YP; He XH; Dong M; Ren H; Jin J; Li YX
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):712-20. PubMed ID: 27034178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Impact of the Bolus in Intensity-Modulated Radiotherapy and Volumetric-Modulated Arc Therapy for Stage I-II Nasal Natural Killer/T-Cell Lymphoma.
    Liu X; Wang Y; Guo Q; Luo H; Luo Q; Li Q; Wu Z; Jin F
    Oncol Res Treat; 2020; 43(4):140-145. PubMed ID: 32018254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents.
    Wang ZY; Li YX; Wang WH; Jin J; Wang H; Song YW; Liu QF; Wang SL; Liu YP; Qi SN; Fang H; Liu XF; Yu ZH
    Blood; 2009 Nov; 114(23):4771-6. PubMed ID: 19812381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility and efficacy of simultaneous integrated boost intensity-modulated radiation therapy in patients with limited-disease small cell lung cancer.
    Han D; Qin Q; Hao S; Huang W; Wei Y; Zhang Z; Wang Z; Li B
    Radiat Oncol; 2014 Dec; 9():280. PubMed ID: 25498196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative dosimetric study of two strategies of intensity-modulated radiotherapy in nasopharyngeal cancer.
    Chen SW; Yang SN; Liang JA; Shiau AC; Lin FJ
    Med Dosim; 2005; 30(4):219-27. PubMed ID: 16275564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity.
    Zheng W; Gao Y; Ke X; Zhang W; Su L; Ren H; Lin N; Xie Y; Tu M; Liu W; Ping L; Ying Z; Zhang C; Deng L; Wang X; Song Y; Zhu J
    BMC Cancer; 2018 Sep; 18(1):910. PubMed ID: 30241515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical differences between primary nasopharyngeal NK/T-cell lymphoma and primary nasal cavity NK/T-cell lymphoma with nasopharynx extension].
    Liu WX; Liu YP; Jin J; Wang SL; Fang H; Ren H; Song YW; Chen B; Lu NN; Li N; Tang Y; Qi SN; Tang Y; Wang WH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):56-62. PubMed ID: 30678418
    [No Abstract]   [Full Text] [Related]  

  • 39. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
    Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pegaspargase Combined with Concurrent Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Two-Center Phase II Study.
    Wang H; Wang L; Li C; Wuxiao Z; Chen G; Luo W; Lu Y
    Oncologist; 2020 Nov; 25(11):e1725-e1731. PubMed ID: 32627928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.